The BRCA2 germline mutation carriers in the present study were at an earlier age, i.e., 67 years (range, 34–89 years), which was similar to previous reports of patients with PCa with BRCA2 mutations having an earlier age of diagnosis (14). This evidence concerns the gene BRCA2 and posterior cortical atrophy.